535 related articles for article (PubMed ID: 26441370)
41. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis.
Haruna S; Shimada C; Ozawa M; Fukami S; Moriyama H
Rhinology; 2009 Mar; 47(1):66-71. PubMed ID: 19382498
[TBL] [Abstract][Full Text] [Related]
42. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Siekmeier R; Hofmann T; Scheuch G
Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
[TBL] [Abstract][Full Text] [Related]
43. Characteristic cell wall ultrastructure of a macrolide-resistant Staphylococcus capitis strain isolated from a patient with chronic sinusitis.
Hyo Y; Yamada S; Harada T
Med Mol Morphol; 2008 Sep; 41(3):160-4. PubMed ID: 18807142
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.
Cervin A; Wallwork B
Curr Allergy Asthma Rep; 2014 Mar; 14(3):416. PubMed ID: 24429901
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery.
Varvyanskaya A; Lopatin A
Int Forum Allergy Rhinol; 2014 Jul; 4(7):533-41. PubMed ID: 24659566
[TBL] [Abstract][Full Text] [Related]
46. Low-dose, long-term macrolide therapy in asthma: An overview.
Hatipoglu U; Rubinstein I
Clin Mol Allergy; 2004 Mar; 2(1):4. PubMed ID: 15023231
[TBL] [Abstract][Full Text] [Related]
47. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity.
Shirai T; Sato A; Chida K
Intern Med; 1995 Jun; 34(6):469-74. PubMed ID: 7549126
[TBL] [Abstract][Full Text] [Related]
48. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
[TBL] [Abstract][Full Text] [Related]
49. Macrolides for diffuse panbronchiolitis.
Lin X; Lu J; Yang M; Dong BR; Wu HM
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007716. PubMed ID: 25618845
[TBL] [Abstract][Full Text] [Related]
50. Macrolides for diffuse panbronchiolitis.
Yang M; Dong BR; Lu J; Lin X; Wu HM
Cochrane Database Syst Rev; 2013 Feb; (2):CD007716. PubMed ID: 23450579
[TBL] [Abstract][Full Text] [Related]
51. Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium.
Tojima I; Shimizu S; Ogawa T; Kouzaki H; Omura S; Sunazuka T; Shimizu T
Auris Nasus Larynx; 2015 Aug; 42(4):332-6. PubMed ID: 25769240
[TBL] [Abstract][Full Text] [Related]
52. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
Rubin BK; Henke MO
Chest; 2004 Feb; 125(2 Suppl):70S-78S. PubMed ID: 14872003
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy.
Suzuki H; Ikeda K; Honma R; Gotoh S; Oshima T; Furukawa M; Takasaka T
ORL J Otorhinolaryngol Relat Spec; 2000; 62(3):121-7. PubMed ID: 10810255
[TBL] [Abstract][Full Text] [Related]
54. Macrolides for diffuse panbronchiolitis.
Yang M; Dong BR; Lu J; Lin X; Wu HM
Cochrane Database Syst Rev; 2010 Dec; (12):CD007716. PubMed ID: 21154381
[TBL] [Abstract][Full Text] [Related]
55. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
56. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.
Serisier DJ
Lancet Respir Med; 2013 May; 1(3):262-74. PubMed ID: 24429132
[TBL] [Abstract][Full Text] [Related]
57. Immunomodulatory effects of macrolides: implications for practicing clinicians.
Siddiqui J
Am J Med; 2004 Nov; 117 Suppl 9A():26S-29S. PubMed ID: 15586561
[TBL] [Abstract][Full Text] [Related]
58. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
Kudoh S
Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
[TBL] [Abstract][Full Text] [Related]
59. Systematic Review and Meta-analysis: Macrolide in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery.
Shu F; Li CX; Zhang F; Peng M; Shi L; Li L; Xiong J; Mu Z; Wang Y; Mao D
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1424-1435. PubMed ID: 37548067
[TBL] [Abstract][Full Text] [Related]
60. The role of atypical infections and macrolide therapy in patients with asthma.
Rollins DR; Good JT; Martin RJ
J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
